Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald J Overmars

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Expert Opinion on Investigational Drugs|February 8, 2023
Investigational drugs for HIV: trends, opportunities and key playersRonald J Overmars, Zoë Krullaars, Thibault Mesplède
Journal of Immunology (Baltimore, Md. : 1950)|May 17, 2017
RIG-I-like Receptor Triggering by Dengue Virus Drives Dendritic Cell Immune Activation and T<sub>H</sub>1 DifferentiationJoris K Sprokholt, Tanja M Kaptein, John L van Hamme, et al.
Plos Pathogens|November 30, 2017
RIG-I-like receptor activation by dengue virus drives follicular T helper cell formation and antibody productionJoris K Sprokholt, Tanja M Kaptein, John L van Hamme, et al.
Viruses|November 25, 2023
Genotypic and Phenotypic Characterization of Replication-Competent HIV-2 Isolated from Controllers and ProgressorsCynthia Lungu, Ronald J Overmars, Esmée Grundeken, et al.
Open Forum Infectious Diseases|July 2, 2025
Insights to a Cure: Unique Controller Phenotypes in the Rotterdam HIV-2 CohortKathryn S Hensley, Rob A Gruters, Els van Nood, et al.
Viruses|September 5, 2020
Inter-Laboratory Reproducibility of Inducible HIV-1 Reservoir Quantification by TILDACynthia Lungu, Francesco A Procopio, Ronald J Overmars, et al.
The Journal of Antimicrobial Chemotherapy|February 4, 2026
Cooperation between HIV-1 integrase natural polymorphism K156N and 3'PPT mutations in dolutegravir monotherapy failureJolieke A T van Osch, Jolanda J C Voermans, Haajar Ouzerne, et al.
Journal of Global Antimicrobial Resistance|November 8, 2022
HIV-1 resistance against dolutegravir fluctuates rapidly alongside erratic treatment adherence: a case reportJeroen J A van Kampen, Hanh Thi Pham, Sunbin Yoo, et al.
Nature Medicine|October 21, 2020
Author Correction: Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the NetherlandsBas B Oude Munnink, David F Nieuwenhuijse, Mart Stein, et al.
Nature Medicine|July 18, 2020
Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the NetherlandsBas B Oude Munnink, David F Nieuwenhuijse, Mart Stein, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Expert Opinion on Investigational Drugs|February 8, 2023
Investigational drugs for HIV: trends, opportunities and key playersRonald J Overmars, Zoë Krullaars, Thibault Mesplède
Journal of Immunology (Baltimore, Md. : 1950)|May 17, 2017
RIG-I-like Receptor Triggering by Dengue Virus Drives Dendritic Cell Immune Activation and T<sub>H</sub>1 DifferentiationJoris K Sprokholt, Tanja M Kaptein, John L van Hamme, et al.
Plos Pathogens|November 30, 2017
RIG-I-like receptor activation by dengue virus drives follicular T helper cell formation and antibody productionJoris K Sprokholt, Tanja M Kaptein, John L van Hamme, et al.
Viruses|November 25, 2023
Genotypic and Phenotypic Characterization of Replication-Competent HIV-2 Isolated from Controllers and ProgressorsCynthia Lungu, Ronald J Overmars, Esmée Grundeken, et al.
Open Forum Infectious Diseases|July 2, 2025
Insights to a Cure: Unique Controller Phenotypes in the Rotterdam HIV-2 CohortKathryn S Hensley, Rob A Gruters, Els van Nood, et al.
Viruses|September 5, 2020
Inter-Laboratory Reproducibility of Inducible HIV-1 Reservoir Quantification by TILDACynthia Lungu, Francesco A Procopio, Ronald J Overmars, et al.
The Journal of Antimicrobial Chemotherapy|February 4, 2026
Cooperation between HIV-1 integrase natural polymorphism K156N and 3'PPT mutations in dolutegravir monotherapy failureJolieke A T van Osch, Jolanda J C Voermans, Haajar Ouzerne, et al.
Journal of Global Antimicrobial Resistance|November 8, 2022
HIV-1 resistance against dolutegravir fluctuates rapidly alongside erratic treatment adherence: a case reportJeroen J A van Kampen, Hanh Thi Pham, Sunbin Yoo, et al.
Nature Medicine|October 21, 2020
Author Correction: Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the NetherlandsBas B Oude Munnink, David F Nieuwenhuijse, Mart Stein, et al.
Nature Medicine|July 18, 2020
Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the NetherlandsBas B Oude Munnink, David F Nieuwenhuijse, Mart Stein, et al.
Pageof 2